Paper digest: Tracking CAR-T cells after infusion

The Paper Digest series highlights outstanding publications demonstrating the advanced use of flow cytometry in clinical research. Here you will find core elements from the work of Blache et al., Front Immunol. 2021, describing a standardized, yet flexibly adaptable framework for identification and comprehensive characterization of CAR-T cells post infusion.

Methodical focus refers to pre-analytical and analytical cytometry process phases.

Cytometry process phases

Pre-formulated dry antibody assays for flow cytometry

Benefit

  • Reduction of technical error
  • Expert antibody panel design
  • Flexible panel adaptation
  • Fast turnaround time
  • Easy reagent storage

Comprehensive CAR-T Cell Phenotyping

Differential Activation/Exhaustion Marker Profiles Between CAR-/+ T Cells

Thin black linehealthy control CAR-

Thick yellow linepatient T-cells CAR-

Thick green linepatient T-cells CAR+

How this study was performed

Whole blood samples from CAR-T recipients and normal donors were stained with DURAClone dry reagents* IM Count, IM TCRs, RE ALB and LUCID custom dry reagents* together with liquid Drop-in reagents. Analyzed with Kaluza software*.

Talk to an expert

Talk to an expert

Blache U, Weiss R, Boldt A, Kapinsky M, Blaudszun AR, Quaiser A, Pohl A, Miloud T, Burgaud M, Vucinic V, Platzbecker U, Sack U, Fricke S, Koehl U. Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications. Front Immunol. 2021 May 3;12:658314, reproduced pursuant to Creative Commons 4.0 Creative Commons Attribution 4.0 International License.

Access the full article

*For research use only. Not for use in diagnostic procedures.